Truist Financial Lowers Option Care Health (NASDAQ:OPCH) Price Target to $34.00

Option Care Health (NASDAQ:OPCH) had its target price trimmed by Truist Financial from $41.00 to $34.00 in a report released on Friday, Benzinga reports. The firm currently has a buy rating on the stock.

A number of other research firms have also recently weighed in on OPCH. Barrington Research lowered their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday. Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $43.00 to $29.00 in a research report on Wednesday. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the company from $38.00 to $26.00 in a report on Thursday. Finally, JMP Securities raised their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and an average target price of $31.60.

Option Care Health Trading Up 4.6 %

OPCH stock traded up $1.07 during midday trading on Friday, hitting $24.11. 7,222,745 shares of the company’s stock were exchanged, compared to its average volume of 1,473,412. Option Care Health has a 1-year low of $22.84 and a 1-year high of $34.63. The business has a 50-day simple moving average of $30.49 and a two-hundred day simple moving average of $29.92. The stock has a market capitalization of $4.10 billion, a PE ratio of 20.26, a P/E/G ratio of 1.79 and a beta of 1.32. The company has a current ratio of 1.73, a quick ratio of 1.36 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.22 billion. On average, sell-side analysts predict that Option Care Health will post 1.22 EPS for the current fiscal year.

Insider Activity

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Harbor Capital Advisors Inc. increased its stake in Option Care Health by 317.9% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after buying an additional 73,312 shares during the period. Comerica Bank grew its holdings in Option Care Health by 6.5% during the first quarter. Comerica Bank now owns 760,915 shares of the company’s stock worth $25,521,000 after acquiring an additional 46,639 shares during the period. Janus Henderson Group PLC lifted its holdings in Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after acquiring an additional 146,837 shares during the period. Edgestream Partners L.P. grew its stake in shares of Option Care Health by 96.8% during the 2nd quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after purchasing an additional 172,845 shares during the period. Finally, XTX Topco Ltd purchased a new position in shares of Option Care Health in the 2nd quarter valued at about $973,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.